Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

argenx

Explore full profile

Platform for antibody lead choice that supports the discovery of human antibody therapeutics

Ghent, BelgiumFounded 2008Biotech & Life Sciences
Valuation $49B Market cap · Aug/2026
Revenue $6.18B Latest reported FY
EBITDA $2.01B Latest reported FY

At a glance

Founded
2008
Headquarters
Ghent, Belgium
Listing
IPO 2014
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
Analysis German diaspora have built $342.5B of unicorns abroad Sep 15, 2026 Analysis The most valuable companies in the German Diaspora Index Sep 15, 2026 Analysis German founders: $342.5B of unicorns abroad, $144.7B at home Sep 15, 2026 Analysis Europe's Decacorns & Centicorns — the Map Aug 23, 2026 News argenx buys Forte Biosciences for $2.2B to expand immunology pipeline Jul 27, 2026

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • MVM Life Science Partners
  • Forbion Capital Partners
  • Omnes Capital
  • KBC
  • Thuja Capital
  • BioGeneration Ventures
  • Erasmus MC Biomedical Fund

Series B and later4 investors entered at this stage

  • OrbiMed
  • EQT Life Sciences
  • PMV
  • Seventure Partners

Talent

Book a demo to see the people
Employees mapped 2,278 incl. 10 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 26 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
28 countries with
team presence
🇺🇸 United States40.5%
🇧🇪 Belgium34.9%
🇬🇧 United Kingdom4.3%
🇨🇭 Switzerland2.6%
🇩🇪 Germany2.5%
Top 5 of 28 shown
Web traffic by country
63K monthly visits
across markets
🇺🇸 United States40%
🇧🇪 Belgium14.3%
🇬🇧 United Kingdom7.3%
🏳️ Korea4%
🏳️ Republic of3.2%
Top 5 markets shown

Patents

Estimated portfolio value
$198M

81 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where argenx was the backer or acquirer, 2019–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across argenx's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        argenx's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about argenx on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See argenx on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles